Login / Signup

Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices.

Anne HermanW UterThomas RustemeyerM MaturaK Aalto-KorteJ Duus JohansenM GonçaloI R WhiteAnna BalatoGimenez-Arnau Ana MariaKnut BrockowC G MortzV MahlerA Goossensnull null
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
There is an urgent need for full and accurate labelling of the chemical composition of MD in contact with the human body.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • high resolution
  • pluripotent stem cells